Medical Innovation Exchange

Inhibikase stock sinks on FDA's unexpected clinical hold for lead asset's Parkinson's trial

https://www.fiercebiotech.com/biotech/inhibikase-stock-sinks-fdas-unexpected-clinical-hold-lead-assets-parkinsons-trial

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!